The 2023 Fall CMTA Report

The 2023 Fall CMTA Report (1581 downloads)

VIEW IN BROWSER

In addition to our regular features, this issue of The CMTA Report is packed with these articles and items of interest:

Novartis Acquires CMT1A Drug Maker DTx Pharma

Treatments for CMT2D Show Promise in Mouse Models

CMT2C Patient Focus Group

Celebrating Awareness Month

Neurotoxic Drug List Updated

Camp Footprint East and West